MX2009007688A - Gel de fibrina para liberacion controlada de tgp-beta y usos del mismo. - Google Patents

Gel de fibrina para liberacion controlada de tgp-beta y usos del mismo.

Info

Publication number
MX2009007688A
MX2009007688A MX2009007688A MX2009007688A MX2009007688A MX 2009007688 A MX2009007688 A MX 2009007688A MX 2009007688 A MX2009007688 A MX 2009007688A MX 2009007688 A MX2009007688 A MX 2009007688A MX 2009007688 A MX2009007688 A MX 2009007688A
Authority
MX
Mexico
Prior art keywords
tgf
beta
controlled release
fibrin gel
disorders
Prior art date
Application number
MX2009007688A
Other languages
English (en)
Inventor
Isabelle Catelas
Sam L Helgerson
Original Assignee
Baxter Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Int filed Critical Baxter Int
Publication of MX2009007688A publication Critical patent/MX2009007688A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1841—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)

Abstract

La presente invención se refiere, en general, a encrustamientos de fibrina, los cuales contienen el factor-beta de crecimiento de transformación (TGF-?) para la liberación controlada in situ para aplicaciones terapéuticas, incluyendo trastornos músculoesqueléticos, tales como trastornos óseos y de cartílago, trastorno de tejido suave y enfermedades cardiovasculares.
MX2009007688A 2007-01-18 2008-01-18 Gel de fibrina para liberacion controlada de tgp-beta y usos del mismo. MX2009007688A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US88145207P 2007-01-18 2007-01-18
US93445707P 2007-06-13 2007-06-13
PCT/US2008/051528 WO2008089466A2 (en) 2007-01-18 2008-01-18 Fibrin gel for controlled release of tgf-beta and uses thereof

Publications (1)

Publication Number Publication Date
MX2009007688A true MX2009007688A (es) 2009-09-28

Family

ID=39636758

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009007688A MX2009007688A (es) 2007-01-18 2008-01-18 Gel de fibrina para liberacion controlada de tgp-beta y usos del mismo.

Country Status (11)

Country Link
US (1) US20080181879A1 (es)
EP (1) EP2142222A2 (es)
JP (1) JP2010516703A (es)
KR (1) KR20090111843A (es)
CN (1) CN101730539A (es)
AU (1) AU2008206052A1 (es)
BR (1) BRPI0806622A2 (es)
CA (1) CA2675157A1 (es)
CO (1) CO6220838A2 (es)
MX (1) MX2009007688A (es)
WO (1) WO2008089466A2 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2282746B8 (en) * 2008-03-27 2015-12-09 Caladrius Biosciences, Inc. Compositions and methods using stem cells in cutaneous wound healing
US8956859B1 (en) 2010-08-13 2015-02-17 Aviex Technologies Llc Compositions and methods for determining successful immunization by one or more vaccines
US9677042B2 (en) 2010-10-08 2017-06-13 Terumo Bct, Inc. Customizable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
US9617506B2 (en) 2013-11-16 2017-04-11 Terumo Bct, Inc. Expanding cells in a bioreactor
EP3613841B1 (en) 2014-03-25 2022-04-20 Terumo BCT, Inc. Passive replacement of media
EP3198006B1 (en) 2014-09-26 2021-03-24 Terumo BCT, Inc. Scheduled feed
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
US20200261618A1 (en) * 2016-01-06 2020-08-20 The Research Foundation For The State University Of New York Liquid tissue graft
US11965175B2 (en) 2016-05-25 2024-04-23 Terumo Bct, Inc. Cell expansion
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
CN106924807A (zh) * 2017-01-17 2017-07-07 华南师范大学 一种修饰纳米导电聚苯胺心脏组织工程支架的制备方法及其应用
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
EP3656842A1 (en) 2017-03-31 2020-05-27 Terumo BCT, Inc. Cell expansion
KR20190092059A (ko) * 2018-01-30 2019-08-07 가톨릭대학교 산학협력단 연골세포, 피브리노겐, 콜라겐 또는 트롬빈을 포함하는 관절경하 수술을 위한 연골 재생용 조성물

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4391904A (en) * 1979-12-26 1983-07-05 Syva Company Test strip kits in immunoassays and compositions therein
US6197325B1 (en) * 1990-11-27 2001-03-06 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US6559119B1 (en) * 1990-11-27 2003-05-06 Loyola University Of Chicago Method of preparing a tissue sealant-treated biomedical material
US5792835A (en) * 1991-09-05 1998-08-11 Baxter International Inc. Method of preparing a topical fibrinogen complex
US6965014B1 (en) * 1996-01-16 2005-11-15 Baxter International Inc. Fibrin material and method for producing and using the same
DE19617369A1 (de) * 1996-04-30 1997-11-06 Immuno Ag Lagerstabile Fibrinogen-Präparate
CA2362513C (en) * 1999-02-12 2011-04-26 Baxter Aktiengesellschaft A method for producing a preparation based on fibrinogen and fibronectin as well as protein compositions obtainable according to this method
US6696073B2 (en) * 1999-02-23 2004-02-24 Osteotech, Inc. Shaped load-bearing osteoimplant and methods of making same
WO2000064481A1 (en) * 1999-04-22 2000-11-02 Eidgenössische Technische Hochschule (ETH) Controlled release of growth factors from heparin containing matrices
US6506365B1 (en) * 2000-09-25 2003-01-14 Baxter Aktiengesellschaft Fibrin/fibrinogen binding conjugate
WO2002083194A1 (en) * 2001-04-12 2002-10-24 Therics, Inc. Method and apparatus for engineered regenerative biostructures
MXPA03009760A (es) * 2001-04-25 2005-10-05 Eidgenoessische Technische Hoc Matrices de suministro de farmacos para mejorar la curacion de heridas.
US20050064042A1 (en) * 2003-04-29 2005-03-24 Musculoskeletal Transplant Foundation Cartilage implant plug with fibrin glue and method for implantation
US20080109035A1 (en) * 2006-10-31 2008-05-08 Henrich Cheng Methods and Compositions for Repairing Common Peroneal Nerve Lesions

Also Published As

Publication number Publication date
WO2008089466A2 (en) 2008-07-24
JP2010516703A (ja) 2010-05-20
US20080181879A1 (en) 2008-07-31
CA2675157A1 (en) 2008-07-24
AU2008206052A1 (en) 2008-07-24
CO6220838A2 (es) 2010-11-19
EP2142222A2 (en) 2010-01-13
BRPI0806622A2 (pt) 2011-09-13
CN101730539A (zh) 2010-06-09
WO2008089466A3 (en) 2009-11-26
KR20090111843A (ko) 2009-10-27

Similar Documents

Publication Publication Date Title
MX2009007688A (es) Gel de fibrina para liberacion controlada de tgp-beta y usos del mismo.
MX2009013970A (es) Gel de fibrina para la liberacion controlada del factor de crecimiento derivado de plaqueta (pdgf) y sus usos.
ATE504317T1 (de) Resorbierbares calciumphosphatbasierendes biopolymervernetztes knochenersatzmaterial
WO2008036502A3 (en) Artificial spinal disc
WO2013192138A3 (en) Novel biological implant compositions, implants and methods related applications
HK1145816A1 (en) Method of forming a bioactive implant material
WO2008130989A3 (en) Prosthetic implants
WO2015009991A8 (en) Methods, systems, and compositions for promoting bone growth
PT1781596E (pt) Pró-fármacos de propofol derivados de aminoácidos, composições e utilizações dos mesmos
WO2010104983A3 (en) Biological tissue connection and repair devices and methods of using same
MX2009004714A (es) Derivados de pirazol fusionado 3-aminocarbonilo sustituidos como moduladores de proteina cinasa.
TN2010000140A1 (en) Compositions and methods for use antibodies against sclerostin
MX368173B (es) Una composición farmacéutica que comprende una proteína de fusión actriia-fc expresada de células cho.
WO2009102452A3 (en) Compositions and methods for implantation of adipose tissue and adipose tissue products
MX2009008918A (es) Activacion de celulas que presentan antigeno humano a traves de clec-6.
MX2009012650A (es) Secuencias de aminoacido dirigidas contra rank-l y polipeptidos que comprenden lo mismo para el tratamiento de enfermedades y trastornos de huesos.
MX2011011768A (es) Composiciones y metodos de uso para moleculas de enlace a dickkopf-1 o dickkopf-4 o a ambos.
DE602007010764D1 (en) Benzamidglucokinaseaktivatoren
ATE547130T1 (de) Biokompatibles implantat
HK1150983A1 (en) Compositions for distraction osteogenesis
MX362405B (es) Composiciones y metodos para procedimientos de fusion de espina.
BR112015019981A2 (pt) configuração melhorada de substituto ósseo rígido
EP2134300A4 (en) CALCIUM PHOSPHATE CEMENTS COMPRISING AN AUTOLOGOUS BONE
MEP0708A (xx) Dobijanje gama-aminokisjelina sa afinitetom za alfa-delta protein
WO2014053906A8 (en) The application of stem cells in the orthodontic maxillary expansion

Legal Events

Date Code Title Description
HH Correction or change in general
FA Abandonment or withdrawal